{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:31:37Z","timestamp":1794562297517,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ajo.2026.05.042","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:18:04Z","timestamp":1780298284000},"page":"231-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Risk of Retinal Detachment After Intravitreal Injection of Anti-VEGF: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"289","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0831-1915","authenticated-orcid":false,"given":"DAVID","family":"MIKHAIL","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BRENDAN K.","family":"TAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PHILIP","family":"YU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LAUREN","family":"CALICCHIA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FAHAD R.","family":"BUTT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"THANANSAYAN","family":"DHIVAGARAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HEBA M.","family":"AL-QATTAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALESSANDRO","family":"FEO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALBERTO","family":"QUARTA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AMIT V.","family":"MISHRA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARK E.","family":"SEAMONE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EDUARDO V.","family":"NAVAJAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PETER J.","family":"KERTES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DAVID T.","family":"WONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAJEEV H.","family":"MUNI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALEXANDER J.","family":"KAPLAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PENG","family":"YAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARKO M.","family":"POPOVIC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2026.05.042_bib0001","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2023.26074","article-title":"Age-related macular degeneration: a review","volume":"331","author":"Fleckenstein","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2026.05.042_bib0002","unstructured":"American Board of Trustees. Intravitreal Injections - 2025. American Academy of Ophthalmology. 2025. Accessed October 25, 2025. https:\/\/www.aao.org\/education\/clinical-statement\/intravitreal-injections-statement."},{"key":"10.1016\/j.ajo.2026.05.042_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2017.12.019","article-title":"Evolution of intravitreal therapy for retinal diseases - from CMV to CNV: the LXXIV Edward Jackson Memorial Lecture","volume":"191","author":"Martin","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.042_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2022-001188","article-title":"Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII)","volume":"7","author":"Wang","year":"2022","journal-title":"BMJ Open Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.05.042_bib0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye (Lond)"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.042_bib0006","doi-asserted-by":"crossref","first-page":"P75","DOI":"10.1016\/j.ophtha.2024.12.020","article-title":"Diabetic retinopathy preferred practice pattern\u00ae","volume":"132","author":"Lim","year":"2025","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2026.05.042_bib0007","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.oret.2024.12.005","article-title":"Endophthalmitis after bilateral same-day versus unilateral intravitreal injection","volume":"9","author":"Tao","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ajo.2026.05.042_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/srep39301","article-title":"Sustained elevation of intraocular pressure associated with intravitreal administration of anti-vascular endothelial growth factor: a systematic review and meta-analysis","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2026.05.042_bib0009","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2026.05.042_bib0010","doi-asserted-by":"crossref","unstructured":"Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, eds. JBI Manual for Evidence Synthesis. JBI. 2024. Accessed October 21, 2025. Available from: https:\/\/synthesismanual.jbi.global.https:\/\/doi.org\/10.46658\/JBIMES-24-01.","DOI":"10.46658\/JBIMES-24-01"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.042_bib0011","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ajo.2026.05.042_bib0012","series-title":". Cochrane Handbook for Systematic Reviews of Interventions version 6.5","article-title":"Chapter 13: Assessing risk of bias due to missing evidence in a meta-analysis [last updated August 2024]","author":"Page","year":"2024"},{"issue":"11","key":"10.1016\/j.ajo.2026.05.042_bib0013","doi-asserted-by":"crossref","first-page":"2304.e3","DOI":"10.1016\/j.ophtha.2011.05.015","article-title":"Retinal detachment after Bevacizumab","volume":"118","author":"Arevalo","year":"2011","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.042_bib0014","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s10384-021-00834-8","article-title":"Characteristics and surgical outcomes of rhegmatogenous retinal detachments that develop after intravitreal injections","volume":"65","author":"Baba","year":"2021","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.042_bib0015","doi-asserted-by":"crossref","DOI":"10.5935\/0004-2749.2024-0277","article-title":"Real-world safety and efficacy of Anti-VEGF treatment in Brazil","volume":"88","author":"Bulla","year":"2025","journal-title":"Arq Bras Oftalmol"},{"issue":"11","key":"10.1016\/j.ajo.2026.05.042_bib0016","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.oret.2022.05.008","article-title":"Incidence, risk factors, and outcomes of rhegmatogenous retinal detachment after intravitreal injections of Anti-VEGF for retinal diseases: data from the fight Retinal blindness! registry","volume":"6","author":"Gabrielle","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.042_bib0017","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/aos.12589","article-title":"Safety Study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a Hospital setting","volume":"93","author":"Hasler","year":"2015","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2026.05.042_bib0018","first-page":"036","article-title":"Ocular safety of intravitreal injections of age-related macular degeneration treatments in a prospective observational cohort study in Europe","volume":"2","author":"Huang","year":"2015","journal-title":"J Clin Res Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2026.05.042_bib0019","first-page":"973","article-title":"Frequency of rhegmatogenous retinal detachment after intravitreal therapy in neovascular age-related macular degeneration","volume":"4","author":"Mammo","year":"2020","journal-title":"OPH Retina"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.042_bib0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1755-3768.2010.02064.x","article-title":"Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections","volume":"89","author":"Meyer","year":"2011","journal-title":"Acta Ophthalmologica"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.042_bib0021","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/eye.2014.231","article-title":"The incidence of serious complications associated with intravitreal therapy in a quaternary ARMD service (2008\u20132014)","volume":"29","author":"Severn","year":"2015","journal-title":"Eye"},{"issue":"10","key":"10.1016\/j.ajo.2026.05.042_bib0022","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/eye.2014.153","article-title":"A safety audit of the first 10\u2009000 intravitreal ranibizumab injections performed by nurse practitioners","volume":"28","author":"Simcock","year":"2014","journal-title":"Eye (Lond)."},{"issue":"10","key":"10.1016\/j.ajo.2026.05.042_bib0023","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ophtha.2019.04.037","article-title":"Rhegmatogenous retinal detachment after intravitreal injection of anti\u2013Vascular endothelial growth factor","volume":"126","author":"Storey","year":"2019","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.042_bib0024","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10792-016-0241-4","article-title":"Safety and complications of intravitreal injections performed in an Asian population in Singapore","volume":"37","author":"Xu","year":"2017","journal-title":"Int Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.05.042_bib0025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ophtha.2023.12.033","article-title":"Risk of endophthalmitis based on cumulative number of anti-VEGF intravitreal injections","volume":"131","author":"Israilevich","year":"2024","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.042_bib0026","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28938-1","article-title":"Risk factors for breakthrough vitreous hemorrhage after intravitreal anti-VEGF injection in age-related macular degeneration with submacular hemorrhage","volume":"8","author":"Shin","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2026.05.042_bib0027","doi-asserted-by":"crossref","DOI":"10.1007\/s00417-025-06875-w","article-title":"Intraocular inflammation following intravitreal injections of anti-vascular endothelial growth factor drugs","author":"Ferreira","year":"2025","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2026.05.042_bib0028","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.oret.2020.09.024","article-title":"Patient-reported complications after intravitreal injection and their predictive factors","volume":"5","author":"Ramos","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"3","key":"10.1016\/j.ajo.2026.05.042_bib0029","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcjo.2012.03.026","article-title":"Rate of serious adverse effects in a series of bevacizumab and ranibizumab injections","volume":"47","author":"Sharma","year":"2012","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.042_bib0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40942-021-00358-w","article-title":"Analysis of urgent follow up visits and complications after intravitreal injections: a retrospective cohort study","volume":"8","author":"Miller","year":"2022","journal-title":"Int J Retina Vitreous"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.042_bib0031","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/08820538.2013.835833","article-title":"Local and systemic complications after intravitreal administration of anti-vascular endothelial growth factor agents in the treatment of different ocular diseases: a five-year retrospective study","volume":"30","author":"Nuzzi","year":"2015","journal-title":"Semin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.05.042_bib0032","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1177\/11206721211059332","article-title":"Ocular adverse events following intravitreal brolucizumab for neovascular age-related macular degeneration at a single tertiary care center","volume":"32","author":"Nguyen","year":"2022","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.042_bib0033","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/bjophthalmol-2019-313991","article-title":"Safety of 6000 Intravitreal dexamethasone Implants","volume":"104","author":"Rajesh","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.042_bib0034","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0008-4182(05)80119-X","article-title":"Complications of intravitreal injection of triamcinolone acetonide","volume":"40","author":"Ozkiri\u015f","year":"2005","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.042_bib0035","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.oret.2020.07.007","article-title":"Rhegmatogenous retinal detachment after intravitreal injection","volume":"5","author":"Brown","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"10.1016\/j.ajo.2026.05.042_bib0036","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1007\/s00417-021-05261-6","article-title":"Intravitreal injection associated rhegmatogenous retinal detachment: outcomes of a European analysis","volume":"259","author":"Vounotrypidis","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426002898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426002898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:18:14Z","timestamp":1794561494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426002898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":36,"alternative-id":["S0002939426002898"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.05.042","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Retinal Detachment After Intravitreal Injection of Anti-VEGF: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.05.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}